TamaBio is promoting the development of Dura Mater Substitute “DuraBeam®︎”, Pericardial Membrane “PeriBeam®︎”, and artificial organs and regenerative medicine technologies in more critical and promising fields. Medical devices such as implants are being developed around the world as functional substitutes for patients’ lost organs, but in clinical settings, various adverse events such as postoperative infections, adhesion with self-tissue, calcification due to long-term use and leakage / blockage of bodily fluids are issues. TamaBio products are highly biocompatible, and overcome these issues through its processing technology, and in recent years have been used as permanent implantation devices or short-term use devices in many surgeries.
The important thing about TamaBio's technology is that it regenerates tissues in the human body, that is, it regenerates important cells and tissues as a whole to maintain their health and restore organ function. It is a technology to produce highly biocompatible polymer compounds, and to process biomembranes to give them the ability to regenerate damaged tissue after implantation.
In addition to the latest developments in nerve injury repair sheets, brain injury repair sheets, and spinal cord injury repair sheets, important research results are being produced daily in the field of cardiovascular surgery and other fields. We would like doctors, researchers, investors, distributors, experts, and managers to participate in TamaBio and deliver cutting-edge technology to the world and to patients.